nad has been researched along with plumbagin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CH; Che, D; Chen, ZJ; Ding, Y; Liu, S; Vetter, M | 1 |
| Ayuso, JM; Barroilhet, L; Beebe, D; Felder, M; Kapur, A; Kumari, S; Patankar, MS; Rehman, S; Skala, MC; Stenerson, Z | 1 |
2 other study(ies) available for nad and plumbagin
| Article | Year |
|---|---|
Inhibition of Nox-4 activity by plumbagin, a plant-derived bioactive naphthoquinone.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Chlorocebus aethiops; COS Cells; Enzyme Inhibitors; Humans; Kidney Neoplasms; NAD; NADP; NADPH Oxidase 4; NADPH Oxidases; Naphthoquinones; Onium Compounds; Plumbaginaceae; Transfection | 2005 |
Oxidative phosphorylation inhibitors inhibit proliferation of endometriosis cells.
Topics: Antimalarials; Antineoplastic Agents; Atovaquone; Cell Proliferation; Curcumin; Endometriosis; Female; Humans; NAD; Oxidative Phosphorylation | 2023 |